One recent animal study found small-molecule versions of the drugs altered the reward circuit within the brains central amygdala region
STEP 1 Study Group
However, a number of factors, including dose, formulation, and type of study population, affect the bioavailability of tocotrienols and may undermine their putative efficacy in humans (14)
Such an effect is mediated by oxidative stress that results from the depletion of GSH following the inhibition of glutathione reductase by carmustine
De Regil, World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults, JAMA , Dec
Supplementation Supplementing GLP-1 is a key way to reach adequate levels, which can be difficult through diet alone